{"entity":{"type":"insider","cik":"0001783952","url":"/insider/0001783952","json_url":"/insider/0001783952.json","name":"Column Group II Management, LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2019-11-04","last":"2020-09-23","span_basis":"filed_date"},"name_variants":[{"name":"Column Group II Management, LP","source":"filing","n_filings":3,"first_seen":"2019-11-04","last_seen":"2020-09-23"}],"transactions":[{"id":2145538,"accession":"0001209191-20-051673","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-051673","line_url":"/filing/0001209191-20-051673#line-1","is_derivative":false,"issuer_cik":"0001182464","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001182464","owner_cik":null,"owner_name":"Column Group II GP, LP; PONOI CAPITAL, LP; Kutzkey Tim; Ponoi Capital II, LP; GOEDDEL DAVID V; Column Group II Management, LP; Ponoi II Management, LLC; Ponoi Management, LLC; COLUMN GROUP II, LP","owner_display_name":"Column Group II GP, LP","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":608000.0,"shares_display":"608,000","price_per_share":30.85,"price_display":"30.85","price_state":"stated","total_value":18756800.0,"total_display":"18,756,800.00","total_whole":"18,756,800","shares_owned_after":3835679.0,"shares_owned_after_display":"3,835,679","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-22","filed_date":"2020-09-23","scope":"insider"},{"id":2647509,"accession":"0001209191-20-047573","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-047573","line_url":"/filing/0001209191-20-047573#line-1","is_derivative":false,"issuer_cik":"0001182464","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001182464","owner_cik":null,"owner_name":"Kutzkey Tim; GOEDDEL DAVID V; Column Group II GP, LP; Ponoi Capital II, LP; Column Group II Management, LP; Ponoi II Management, LLC; COLUMN GROUP II, LP; PONOI CAPITAL, LP; Ponoi Management, LLC","owner_display_name":"Kutzkey Tim","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":538654.0,"shares_display":"538,654","price_per_share":22.75,"price_display":"22.75","price_state":"stated","total_value":12254378.5,"total_display":"12,254,378.50","total_whole":"12,254,379","shares_owned_after":4443679.0,"shares_owned_after_display":"4,443,679","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-19","scope":"insider"},{"id":7928673,"accession":"0001209191-19-054999","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-19-054999","line_url":"/filing/0001209191-19-054999#line-7","is_derivative":false,"issuer_cik":"0001600420","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001600420","owner_cik":null,"owner_name":"Svennilson Peter; Ponoi II Management, LLC; COLUMN GROUP II, LP; PONOI CAPITAL, LP; Ponoi Capital II, LP; Column Group II GP, LP; Ponoi Management, LLC; Kutzkey Tim; Column Group II Management, LP","owner_display_name":"Svennilson Peter","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":625000.0,"shares_display":"625,000","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":7500000.0,"total_display":"7,500,000.00","total_whole":"7,500,000","shares_owned_after":4982333.0,"shares_owned_after_display":"4,982,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-04","filed_date":"2019-11-04","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001673772","name":"RAPT Therapeutics, Inc.","url":"/issuer/0001673772","role":"Ten percent owner","n_filings":3,"first_seen":"2019-11-04","last_seen":"2020-09-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001783952","retrieved_at":"2026-08-23T23:18:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}